MedPath

Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors

Not Applicable
Terminated
Conditions
Breast Cancer
Interventions
Other: Magnetic Resonance Angiography (MRA) of the Breast
Registration Number
NCT00630292
Lead Sponsor
University of North Carolina, Chapel Hill
Brief Summary

This is a pilot study designed to explore the feasibility of non-invasively diagnosing the presence of cancer in the breast using non-invasive magnetic resonance imaging (MRI) methods and an analysis of vessel shape defined from these magnetic resonance images.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
6
Inclusion Criteria
  • adult women (age >= 18),
  • with Histologically documented newly diagnosed stage II-IV invasive breast cancer appropriate for neoadjuvant (preoperative) systemic therapy.
  • ECOG performance status of 0, 1, or 2 at the initiation of the study.
Read More
Exclusion Criteria
  • pregnant women
  • women with contralateral mastectomies
  • known bilateral tumors
  • subjects prone to claustrophobia
  • contraindicated to have MRI
  • mentally impaired
  • not fluent in english
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Magnetic Resonance Angiography (MRA) of the Breast-
Primary Outcome Measures
NameTimeMethod
Amount of Blood Vessel Tortuosity in Breast With Known Cancerup to two weeks prior to start of chemotheraphy

Amount of vessel tortuosity before the start of neoadjuvant chemotherapy and at the end of neoadjuvant chemotherapy

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UNC Hospitals

🇺🇸

Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath